Simtra BioPharma Solutions News and Resources

Simtra BioPharma Solutions, a contract development and manufacturing organisation (CDMO) focused on sterile injectables, has completed construction of a new production building at its Halle, Germany campus. This expansion forms part of the company’s efforts to meet growing global demand

Simtra BioPharma Solutions, a contract development and manufacturing organisation (CDMO) focused on sterile injectables, has announced a five-year strategic partnership with the Life Science business of Merck KGaA, Darmstadt, Germany. Known as MilliporeSigma in the US and Canada, Merck’s Life

Simtra BioPharma Solutions, a pharmaceutical manufacturing company, is investing $250 million to expand its sterile fill/finish manufacturing campus in Bloomington, Indiana. The expansion, supported by a $500,000 allocation from the state’s Regional Economic Acceleration and Development Initiative (READI) 2.0, will

Simtra BioPharma Solutions, a injectable contract development and manufacturing organisation (CDMO), has announced a $250+ million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana.  A new, state-of-the-art 150,000 square foot building will be constructed to house two high-speed